Friends of Cancer Research Statement on Prescription Drug User Fee Act (PDUFA) Agreement September 1, 2011 Click Here to Read Statement Read More In the News BioCentury – Makary: New ultrarare path will provide approval based on ‘plausible mechanism’ In the News The Cancer Letter – Lung-MAP trial for NSCLC expands genomic screening options for patients
In the News BioCentury – Makary: New ultrarare path will provide approval based on ‘plausible mechanism’
In the News The Cancer Letter – Lung-MAP trial for NSCLC expands genomic screening options for patients
